Abstract

Animal experiments have suggested that the drug Mycophenolic Acid may be a radiosensitizer. This brief communication describes a clinical trial of the drug in patients with two or more similar skin metastases or with bilateral lung metastases. The patients acted as their own controls, receiving two types of treatment on separate occasions using either Radiotherapy alone or Radiotherapy with Mycophenolic Acid. The study failed to show synergism between radiotherapy and the drug in metastatic tumours of the breast, stomach, caecum and testes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call